Research ArticleArticle
Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950
Melissa Richard-Lalonde
Centre de Recherche de l’Hôpital Sainte-Justine (M.R.-L., K.N., N.A., G.P.); Département de Pharmacologie (M.R.-L., K.N., N.A., G.P.), Département de Psychiatrie (G.P.), and Faculté de Médecine and Institut de Recherche en Immunologie et en Cancérologie (M.H., M.B.), Université de Montréal; Department of Pharmacology and Therapeutics, McGill University (R.S., T.E.H.); and the Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal (P.W.S.), Montréal, Québec, Canada, and the Department of Life and Environment Sciences, University of Cagliari, Italy (G.B.)
Karim Nagi
Centre de Recherche de l’Hôpital Sainte-Justine (M.R.-L., K.N., N.A., G.P.); Département de Pharmacologie (M.R.-L., K.N., N.A., G.P.), Département de Psychiatrie (G.P.), and Faculté de Médecine and Institut de Recherche en Immunologie et en Cancérologie (M.H., M.B.), Université de Montréal; Department of Pharmacology and Therapeutics, McGill University (R.S., T.E.H.); and the Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal (P.W.S.), Montréal, Québec, Canada, and the Department of Life and Environment Sciences, University of Cagliari, Italy (G.B.)
Nicolas Audet
Centre de Recherche de l’Hôpital Sainte-Justine (M.R.-L., K.N., N.A., G.P.); Département de Pharmacologie (M.R.-L., K.N., N.A., G.P.), Département de Psychiatrie (G.P.), and Faculté de Médecine and Institut de Recherche en Immunologie et en Cancérologie (M.H., M.B.), Université de Montréal; Department of Pharmacology and Therapeutics, McGill University (R.S., T.E.H.); and the Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal (P.W.S.), Montréal, Québec, Canada, and the Department of Life and Environment Sciences, University of Cagliari, Italy (G.B.)
Rory Sleno
Centre de Recherche de l’Hôpital Sainte-Justine (M.R.-L., K.N., N.A., G.P.); Département de Pharmacologie (M.R.-L., K.N., N.A., G.P.), Département de Psychiatrie (G.P.), and Faculté de Médecine and Institut de Recherche en Immunologie et en Cancérologie (M.H., M.B.), Université de Montréal; Department of Pharmacology and Therapeutics, McGill University (R.S., T.E.H.); and the Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal (P.W.S.), Montréal, Québec, Canada, and the Department of Life and Environment Sciences, University of Cagliari, Italy (G.B.)
Mohammad Amraei
Centre de Recherche de l’Hôpital Sainte-Justine (M.R.-L., K.N., N.A., G.P.); Département de Pharmacologie (M.R.-L., K.N., N.A., G.P.), Département de Psychiatrie (G.P.), and Faculté de Médecine and Institut de Recherche en Immunologie et en Cancérologie (M.H., M.B.), Université de Montréal; Department of Pharmacology and Therapeutics, McGill University (R.S., T.E.H.); and the Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal (P.W.S.), Montréal, Québec, Canada, and the Department of Life and Environment Sciences, University of Cagliari, Italy (G.B.)
Mireille Hogue
Centre de Recherche de l’Hôpital Sainte-Justine (M.R.-L., K.N., N.A., G.P.); Département de Pharmacologie (M.R.-L., K.N., N.A., G.P.), Département de Psychiatrie (G.P.), and Faculté de Médecine and Institut de Recherche en Immunologie et en Cancérologie (M.H., M.B.), Université de Montréal; Department of Pharmacology and Therapeutics, McGill University (R.S., T.E.H.); and the Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal (P.W.S.), Montréal, Québec, Canada, and the Department of Life and Environment Sciences, University of Cagliari, Italy (G.B.)
Gianfranco Balboni
Centre de Recherche de l’Hôpital Sainte-Justine (M.R.-L., K.N., N.A., G.P.); Département de Pharmacologie (M.R.-L., K.N., N.A., G.P.), Département de Psychiatrie (G.P.), and Faculté de Médecine and Institut de Recherche en Immunologie et en Cancérologie (M.H., M.B.), Université de Montréal; Department of Pharmacology and Therapeutics, McGill University (R.S., T.E.H.); and the Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal (P.W.S.), Montréal, Québec, Canada, and the Department of Life and Environment Sciences, University of Cagliari, Italy (G.B.)
Peter W. Schiller
Centre de Recherche de l’Hôpital Sainte-Justine (M.R.-L., K.N., N.A., G.P.); Département de Pharmacologie (M.R.-L., K.N., N.A., G.P.), Département de Psychiatrie (G.P.), and Faculté de Médecine and Institut de Recherche en Immunologie et en Cancérologie (M.H., M.B.), Université de Montréal; Department of Pharmacology and Therapeutics, McGill University (R.S., T.E.H.); and the Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal (P.W.S.), Montréal, Québec, Canada, and the Department of Life and Environment Sciences, University of Cagliari, Italy (G.B.)
Michel Bouvier
Centre de Recherche de l’Hôpital Sainte-Justine (M.R.-L., K.N., N.A., G.P.); Département de Pharmacologie (M.R.-L., K.N., N.A., G.P.), Département de Psychiatrie (G.P.), and Faculté de Médecine and Institut de Recherche en Immunologie et en Cancérologie (M.H., M.B.), Université de Montréal; Department of Pharmacology and Therapeutics, McGill University (R.S., T.E.H.); and the Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal (P.W.S.), Montréal, Québec, Canada, and the Department of Life and Environment Sciences, University of Cagliari, Italy (G.B.)
Terence E. Hébert
Centre de Recherche de l’Hôpital Sainte-Justine (M.R.-L., K.N., N.A., G.P.); Département de Pharmacologie (M.R.-L., K.N., N.A., G.P.), Département de Psychiatrie (G.P.), and Faculté de Médecine and Institut de Recherche en Immunologie et en Cancérologie (M.H., M.B.), Université de Montréal; Department of Pharmacology and Therapeutics, McGill University (R.S., T.E.H.); and the Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal (P.W.S.), Montréal, Québec, Canada, and the Department of Life and Environment Sciences, University of Cagliari, Italy (G.B.)
Graciela Pineyro
Centre de Recherche de l’Hôpital Sainte-Justine (M.R.-L., K.N., N.A., G.P.); Département de Pharmacologie (M.R.-L., K.N., N.A., G.P.), Département de Psychiatrie (G.P.), and Faculté de Médecine and Institut de Recherche en Immunologie et en Cancérologie (M.H., M.B.), Université de Montréal; Department of Pharmacology and Therapeutics, McGill University (R.S., T.E.H.); and the Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal (P.W.S.), Montréal, Québec, Canada, and the Department of Life and Environment Sciences, University of Cagliari, Italy (G.B.)
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Kir3.1//Kir3.2 Channel Activation by DORs
Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
Molecular Pharmacology February 1, 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950
Research ArticleArticle
Kir3.1//Kir3.2 Channel Activation by DORs
Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
Molecular Pharmacology February 1, 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement